Recall Alert: Airsupra Inhalers Recalled for Defective Delivery System

AstraZenca is recalling more than 1 million inhalers for a defective delivery system. Recalled inhalers might not work properly. If you have a recalled inhaler, contact your pharmacist or doctor as soon as possible. Have a backup option for a quick-relief medicine until you can replace the inhaler.

Product Description

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in:

  1. 120-inhalation canister (NDC 0310-9080-12)
  2. 28-inhalation canister (NDC 0310-9080-28)

Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France

Recall Number

D-0444-2025

Classification

Class II

Code Information

Lot#:

  1. 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027

  2. Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026

Product Quantity

a) 807,837 canisters; b) 235,698 canisters

Reason for Recall

Defective delivery system